Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($57.3M) | ($361.2M) | ($582.9M) | ($440.9M) | ($544.6M) | ($1,131.1M) | ($494.4M) | ($513.0M) | ($610.6M) | ($958.5M) | ($544.4M) | ($216.2M) | ($874.4M) | ($1,459.7M) | ($2,571.6M) | ($3,146.6M) | ($6,044.4M) | ($6,557.5M) | ($9,878.8M) | ($10.4B) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Vertex Pharmaceuticals Incorporated's last 12-month Net Debt is ($4,821.6M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Vertex Pharmaceuticals Incorporated's Net Debt growth was (53.8%). The average annual Net Debt growth rates for Vertex Pharmaceuticals Incorporated have been (7.2%) over the past three years, 7.3% over the past five years.
Over the last year, Vertex Pharmaceuticals Incorporated's Net Debt growth was (53.8%), which is lower than industry growth of (0.1%). It indicates that Vertex Pharmaceuticals Incorporated's Net Debt growth is Good.